Literature DB >> 30347393

Medication Adherence of Statin Users after Acute Ischemic Stroke.

Pil-Wook Chung1, Byung-Woo Yoon2, Yeong-Bae Lee3, Byoung-Soo Shin4, Hahn Young Kim5, Jae Hyeon Park6, Byung-Kun Kim7, Bong-Goo Yoo8, Won-Chul Shin9, Eung-Gyu Kim10, Jin Kuk Do11, Kyung-Pil Park12, Yohan Jung13, Woo-Keun Seo14,15, Moon-Ku Han16, Jei Kim17, Yongduk Kim18, Oh Young Bang15, Yang-Ha Hwang19, Jin-Hye Cha20, Young-Joo Kim20.   

Abstract

Although statins are established therapy for the secondary prevention of ischemic stroke, factors associated with adherence to statin treatment following ischemic stroke are not well known. To address this, we assessed the 6-month statin adherence using 8-item Morisky Medication Adherence Scale-8 in patients with acute ischemic stroke. Of 991 patients, 65.6% were adherent to statin at 6-month after discharge. Multiple logistic regression analysis showed that patients' awareness of hyperlipidemia (OR 1.62; 95% CI 1.07-2.43), large artery stroke subtype (versus non-large artery stroke, OR 1.79; 95% CI 1.19-2.68), and alcohol drinking habits (OR 1.64; 95% CI 1.06-2.53) were positively associated, while high statin dose (versus low dose, OR 0.6; 95% CI 0.40-0.90) and higher daily number of medication pills (OR 0.93; 95% CI 0.88-0.97) were found to have a negative association with self-reported good adherence to statin medication after acute ischemic stroke. However, stroke severity and diagnosis of hyperlipidemia were not associated with adherence. These results suggest that educational and motivational interventions may enhance statin adherence because modifiable factors were associated with statin adherence.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute ischemic stroke; Patient-reported outcomes; Quality of life; Statin adherence

Mesh:

Substances:

Year:  2018        PMID: 30347393     DOI: 10.1159/000493530

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

1.  The influence of statin withdrawal and adherence on stroke outcomes.

Authors:  Bruno Kusznir Vitturi; Rubens José Gagliardi
Journal:  Neurol Sci       Date:  2020-10-10       Impact factor: 3.307

2.  Prevalence of pharmacological adherence in patients with coronary artery disease and associated factors.

Authors:  Jaqueline Correia Padilha; Vinicius Batista Santos; Camila Takao Lopes; Juliana de Lima Lopes
Journal:  Rev Lat Am Enfermagem       Date:  2021-09-03

3.  Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study.

Authors:  Helena Norberg; Maria Sjölander; Eva-Lotta Glader; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2022-02-14       Impact factor: 2.953

Review 4.  Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review.

Authors:  João Lopes; Paulo Santos
Journal:  Patient Prefer Adherence       Date:  2021-08-24       Impact factor: 2.711

5.  Development and validation of the Health Education Adherence Scale for Stroke Patients: a cross-sectional study.

Authors:  Weiwei Ding; Junya Chen; Jing Liu; Beibei Lin; Shihen Li; Fengzhen Li; Junyi Guo; Yun Li; Jufang Li
Journal:  BMC Neurol       Date:  2022-02-28       Impact factor: 2.474

Review 6.  Inclusion of People with Disabilities in Research to Improve Medication Adherence: A Systematic Review.

Authors:  Jaclyn K Schwartz; Elizabeth Unni
Journal:  Patient Prefer Adherence       Date:  2021-07-26       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.